IndiaOne Finance - Company Dashboard

Governance Classic Home

Aarti Pharmalabs LtdPharmaceuticalsINE0LRU01027Consolidated₹820.85+2.20 (+0.27%)Jun-26

Valuation

Market Cap₹7.44K Cr

TTM PE34.90x

Forward PE30.12x

PEG2.44

Book Value₹234.30

P/B3.50x

TTM EPS₹23.51

Fwd EPS₹27.24

TTM Revenue₹1.97K Cr

TTM PAT₹213.14 Cr

TTM EBITDA₹426.29 Cr

TTM EBIT₹314.71 Cr

Last Qtr PAT₹76.14 Cr

Last Qtr EBITDA₹136.12 Cr

Last Qtr EBIT₹106.09 Cr

Profitability

ROE10.03%

ROCE11.12%

TTM NPM10.82%

TTM EBITDA %21.65%

Curr OPM14.20%

Last OPM10.35%

Curr NPM—

Last NPM—

Curr EPS₹8.40

Last EPS₹6.74

Balance sheet

Equity₹45.33 Cr

Reserve₹2.08K Cr

Total Debt₹754.36 Cr

D/E0.36x

Interest %16.92%

Curr Interest₹12.88 Cr

Price / range

Close₹820.40

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D-0.79%

1W-0.97%

1M-5.84%

3M+24.70%

6M+25.25%

1Y-8.92%

2Y+24.78%

3Y+80.07%

5Y—

Diwali+10.29%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	36.45	14.50%
DIVISLAB	9375.00	₹2.49L Cr	85.06	17.45%
TORNTPHARM	4840.00	₹1.84L Cr	77.32	25.70%
ZYDUSLIFE	1160.00	₹1.16L Cr	25.85	16.94%
CIPLA	1394.50	₹1.13L Cr	33.41	9.75%
LAURUSLABS	1954.00	₹1.06L Cr	96.45	20.58%
AUROPHARMA	1734.00	₹99.77K Cr	27.09	9.79%
DRREDDY	1185.00	₹98.91K Cr	30.63	8.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	534.59+42.4%	579.70	425.25	417.29	375.31	1,797.55
Other Income	2.93	10.53	-0.37	3.15	1.60	15.32
Total Income	537.52+42.6%	590.23	424.88	420.44	376.91	1,812.87
Interest	12.87	16.86	12.58	10.66	6.79	46.90
Expenditure	-441.30-42.5%	-507.65	-363.51	-378.74	-309.73	-1,575.84
PBDT	0	0	0	0	0	0
EBITDA	136.19+43.2%	117.07	102.94	73.98	95.13	372.91
Depreciation	-30.03	-28.16	-28.62	-24.77	-22.76	-104.30
EBIT	106.16+46.7%	88.91	74.32	49.21	72.37	268.61
PBT	96.22+43.2%	82.59	58.58	41.70	67.17	234.24
Tax	-24.92	-20.55	-14.74	-10.77	-15.95	-58.04
Equity	45.34	45.33	45.33	0	45.32	45.33
OPM	17.90	13.99	13.79	9.99	17.82	12.92
Net Profit	71.31+39.2%	62.03	43.84	30.93	51.22	176.20
NPM	13.27	10.51	10.32	7.41	13.59	9.72
EPS	7.87	6.84	4.84	3.41	0	19.44

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23
Revenue	1,797.55+1.5%	1,771.35+17.9%	1,502.13-0.6%	1,511.25
Other Income	15.32	14.49	11.01	1.28
Total Income	1,812.87+1.5%	1,785.84+18.0%	1,513.14+0.0%	1,512.53
Expenditure	-1,575.84-8.7%	-1,449.50-17.0%	-1,238.62+3.2%	-1,279.17
Interest	-46.90	-25.63	-16.64	-20.48
PBDT	0	0	0	0
EBITDA	372.91-12.6%	426.54+23.2%	346.16+12.3%	308.33
Depreciation	-104.30	-79.06	-66.01	-55.77
EBIT	268.61-22.7%	347.48+24.0%	280.15+10.9%	252.56
PBT	234.24-30.4%	336.34+22.5%	274.52+17.6%	233.36
Tax	-58.04	-78.99	-73.87	-61.63
Equity	45.33	45.32	0	0
OPM (%)	12.92	18.83	18.00	15.00
Net Profit	176.20-31.5%	257.35+28.3%	200.65+16.8%	171.73
NPM (%)	9.72	14.41	13.00	11.00
EPS (Rs)	19.44-31.5%	28.39+28.2%	22.14+16.8%	18.95
CEPS	19.42	28.38	22.14	18.85

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	535.80+38.7%	582.64	432.27	418.34	386.19	1,819.44
Other Income	0.45	8.05	-0.37	0.05	1.60	9.75
Total Income	536.25+38.3%	590.70	431.90	418.39	387.79	1,829.19
Interest	12.88	16.86	12.58	10.67	6.79	46.90
Expenditure	-442.59-38.1%	-514.53	-371.16	-379.05	-320.54	-1,601.47
PBDT	0	0	0	0	0	0
EBITDA	136.12+42.9%	113.13	102.31	74.73	95.23	369.21
Depreciation	-30.03	-28.16	-28.62	-24.77	-22.79	-104.34
EBIT	106.09+46.5%	84.97	73.69	49.96	72.44	264.87
PBT	93.65+39.3%	76.17	57.95	39.34	67.25	224.92
Tax	-24.92	-20.55	-14.91	-10.77	-15.95	-58.21
Equity	45.34	45.33	45.32	0	45.32	45.33
OPM	17.46	12.89	13.42	9.40	17.34	12.30
Net Profit	76.14+53.8%	61.12	47.96	27.92	49.50	174.71
NPM	14.20	10.35	11.10	6.67	12.76	9.55
EPS	8.40+53.8%	6.74	5.29	3.08	5.46	19.27

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23
Revenue	1,819.44-14.0%	2,115.07+14.2%	1,852.61-4.8%	1,945.23
Other Income	9.75	10.12	4.90	2.32
Total Income	1,829.19-13.9%	2,125.19+14.4%	1,857.50-4.6%	1,947.55
Expenditure	-1,601.47+9.2%	-1,764.50-13.3%	-1,557.01+7.7%	-1,686.78
Interest	-46.90	-26.90	-17.21	-21.05
PBDT	0	0	0	0
EBITDA	369.21-20.5%	464.37+20.3%	386.05+12.9%	342.04
Depreciation	-104.34	-86.90	-73.24	-62.54
EBIT	264.87-29.8%	377.47+20.7%	312.81+11.9%	279.50
PBT	224.92-37.6%	360.69+20.0%	300.49+15.2%	260.77
Tax	-58.21	-88.28	-83.59	-67.28
Equity	45.33	45.32	0	0
OPM (%)	12.30	16.97	16.18	13.39
Net Profit	174.71-35.9%	272.40+25.6%	216.90+12.1%	193.49
NPM (%)	9.55	12.82	11.68	9.94
EPS (Rs)	19.27-35.9%	30.06+25.6%	23.93+12.1%	21.35
CEPS	19.25	30.04	23.93	21.35

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2026	Interim Dividend	1.5	16 Feb 2026
2025	Final Dividend	2.5	15 Sep 2025
2025	Interim Dividend	2.5	14 Feb 2025
2024	Final Dividend	1	31 Jul 2024
2024	Interim Dividend	2	16 Feb 2024

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split